
Loading, please wait...

Loading, please wait...

The ICU Visits randomised clinical trial evaluated whether flexible family visitation could reduce delirium in adult ICU patients. Across 36 Brazilian ICUs, flexible visiting—up to 12 hours per day with family education—was compared with usual restricted visitation. The primary outcome was delirium incidence. Despite substantially longer family presence, delirium was not significantly reduced. This is clinically useful because it prevents an intuitive but unsupported assumption that more family presence alone will automatically prevent delirium. However, the intervention was associated with better anxiety and depression scores among family members. That finding matters in an ICU model built around humanisation: an intervention can have meaningful benefits even when the primary patient-centred outcome does not change. For HCPs, the lesson is to distinguish the goals of family visitation. Families may support orientation, communication, shared decisions and emotional wellbeing, but delirium prevention still requires a wider strategy that includes sleep, mobility, sedation optimisation and cognitive engagement. The study fits CritiCARE 2026's family-presence and humanisation themes while illustrating the importance of testing compassionate practices rather than assuming their effects. It is a good example of how patient outcomes and family outcomes should both be considered when designing ICU policies.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The ICU Visits randomised clinical trial evaluated whether flexible family visitation could reduce delirium in adult ICU patients. Across 36 Brazilian ICUs, flexible visiting—up to 12 hours per day with family education—was compared with usual restricted visitation. The primary outcome was delirium incidence. Despite substantially longer family presence, delirium was not significantly reduced. This is clinically useful because it prevents an intuitive but unsupported assumption that more family presence alone will automatically prevent delirium. However, the intervention was associated with better anxiety and depression scores among family members. That finding matters in an ICU model built around humanisation: an intervention can have meaningful benefits even when the primary patient-centred outcome does not change. For HCPs, the lesson is to distinguish the goals of family visitation. Families may support orientation, communication, shared decisions and emotional wellbeing, but delirium prevention still requires a wider strategy that includes sleep, mobility, sedation optimisation and cognitive engagement. The study fits CritiCARE 2026's family-presence and humanisation themes while illustrating the importance of testing compassionate practices rather than assuming their effects. It is a good example of how patient outcomes and family outcomes should both be considered when designing ICU policies.
Today

The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back

A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back

Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back

A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back